Halia Therapeutics Announces Positive Phase 2a Data for Ofirnoflast in Lower-Risk MDS at ASH 2025
– New findings demonstrate a 72% HI-E response rate at Week 16…
HTX Group’s Affiliate HBGL Announces Soft Launch in Australia, Introducing Compliant Fiat-Stablecoin Services
PANAMA CITY, Panama, Dec. 8, 2025 /PRNewswire/ -- HBGL, a licensed digital asset…
TScan Therapeutics Announces Positive Updated Data from the ALLOHA Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition
December 06, 2025 17:30 ET | Source: TScan Therapeutics, Inc. Treatment arm…
Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
December 06, 2025 17:30 ET | Source: Fulcrum Therapeutics, Inc. ― Clear…
Strutt ev the CES 2026 Best of Innovation Winner Announces Super Early Bird Begins
The awards-winning robotics company officially kicks off its pre-order window ahead of…
Rocket Doctor Announces Granting of RSUs and Options and a Change of CFO
December 05, 2025 17:00 ET | Source: Rocket Doctor AI Inc. Vancouver,…
Global Mofy AI Limited Announces US$4.8 Million Private Placement Financing
BEIJING, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Global Mofy AI Limited (the…
Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
DALLAS, Dec. 5, 2025 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango" or…
Symbotic Announces Pricing of Primary and Secondary Offering of Class A Common Stock
December 04, 2025 22:05 ET | Source: Symbotic Inc. WILMINGTON, Mass., Dec.…
Protara Announces Pricing of $75 Million Public Offering
December 04, 2025 22:03 ET | Source: Protara Therapeutics NEW YORK, Dec.…
